Hmdb loader
You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on Human Metabolome Database.
Record Information
Version5.0
StatusDetected and Quantified
Creation Date2007-04-12 17:44:49 UTC
Update Date2021-10-13 04:47:44 UTC
HMDB IDHMDB0005923
Secondary Accession Numbers
  • HMDB05923
Metabolite Identification
Common NameN4-Acetylcytidine
DescriptionN4-Acetylcytidine is a modified nucleoside. N4-acetylcytidine is an endogenous urinary nucleoside product of the degradation of transfer ribonucleic acid (tRNA); urinary nucleosides are biological markers for patients with colorectal cancer. tRNA has been shown to be excreted in abnormal amounts in the urine of cancer patients. tRNA from neoplastic tissue had a much more rapid turnover rate than the tRNA from the corresponding normal tissue. Evidence indicates that methylation of tRNA occurs only after synthesis of the intact macromolecule. Because there are no specific enzyme systems to incorporate the modified nucleosides into the macromolecular nucleic acid, these nucleosides once released in the process of tRNA turnover cannot be reutilized, nor are they further degraded, but are excreted in urine. (PMID: 15991285 , 3506820 ).
Structure
Data?1582752369
Synonyms
ValueSource
4-Acetyl-1-(beta-D-ribofuranosyl)cytosineChEBI
N-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-2-oxo-1,2-dihydropyrimidin-4-yl}acetamideChEBI
4-Acetyl-1-(b-D-ribofuranosyl)cytosineGenerator
4-Acetyl-1-(β-D-ribofuranosyl)cytosineGenerator
4-Acetyl-1-(beta-delta-ribofuranosyl)cytosineHMDB
4-AcetylcytidineHMDB
N-4-AcetylcytidineHMDB
N-Acetyl-cytidineHMDB
N-AcetylcytidineHMDB
AcetylcytidineMeSH, HMDB
Chemical FormulaC11H15N3O6
Average Molecular Weight285.2533
Monoisotopic Molecular Weight285.096085227
IUPAC NameN-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-1,2-dihydropyrimidin-4-yl}acetamide
Traditional NameN4-acetylcytidine
CAS Registry Number3768-18-1
SMILES
CC(=O)NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
InChI Identifier
InChI=1S/C11H15N3O6/c1-5(16)12-7-2-3-14(11(19)13-7)10-9(18)8(17)6(4-15)20-10/h2-3,6,8-10,15,17-18H,4H2,1H3,(H,12,13,16,19)/t6-,8-,9-,10-/m1/s1
InChI KeyNIDVTARKFBZMOT-PEBGCTIMSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as pyrimidine nucleosides. Pyrimidine nucleosides are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety.
KingdomOrganic compounds
Super ClassNucleosides, nucleotides, and analogues
ClassPyrimidine nucleosides
Sub ClassNot Available
Direct ParentPyrimidine nucleosides
Alternative Parents
Substituents
  • Pyrimidine nucleoside
  • Glycosyl compound
  • N-glycosyl compound
  • Pentose monosaccharide
  • Pyrimidone
  • Hydropyrimidine
  • Monosaccharide
  • Pyrimidine
  • Tetrahydrofuran
  • Heteroaromatic compound
  • Secondary alcohol
  • Organoheterocyclic compound
  • Organic 1,3-dipolar compound
  • Propargyl-type 1,3-dipolar organic compound
  • Carboximidic acid
  • Oxacycle
  • Azacycle
  • Carboximidic acid derivative
  • Hydrocarbon derivative
  • Organooxygen compound
  • Organonitrogen compound
  • Alcohol
  • Organic oxygen compound
  • Organic nitrogen compound
  • Organopnictogen compound
  • Primary alcohol
  • Organic oxide
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External Descriptors
Ontology
Physiological effect

Adverse health effect

Disposition

Biological location

Source

Route of exposure

Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water Solubility1000000 mg/L @ 25 °C (est)The Good Scents Company Information System
LogPNot AvailableNot Available
Experimental Chromatographic Properties

Experimental Collision Cross Sections

Adduct TypeData SourceCCS Value (Å2)Reference
[M-H]-MetCCS_train_neg161.40330932474
[M+H]+MetCCS_train_pos162.72930932474
[M-H]-Not Available161.403http://allccs.zhulab.cn/database/detail?ID=AllCCS00000140
[M+H]+Not Available162.975http://allccs.zhulab.cn/database/detail?ID=AllCCS00000140
Predicted Molecular Properties
PropertyValueSource
Water Solubility12.3 g/LALOGPS
logP10(-1.4) g/LALOGPS
logP10(-2.9) g/LChemAxon
logS10(-1.4) g/LALOGPS
pKa (Strongest Acidic)12.47ChemAxon
pKa (Strongest Basic)-3ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area131.69 ŲChemAxon
Rotatable Bond Count3ChemAxon
Refractivity63.99 m³·mol⁻¹ChemAxon
Polarizability27.16 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+164.16631661259
DarkChem[M-H]-160.7131661259

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
N4-AcetylcytidineCC(=O)NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O3994.2Standard polar33892256
N4-AcetylcytidineCC(=O)NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O2472.3Standard non polar33892256
N4-AcetylcytidineCC(=O)NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O2963.5Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
N4-Acetylcytidine,1TMS,isomer #1CC(=O)NC1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O)[C@H]2O)C=C12708.8Semi standard non polar33892256
N4-Acetylcytidine,1TMS,isomer #2CC(=O)NC1=NC(=O)N([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C)[C@H]2O)C=C12711.2Semi standard non polar33892256
N4-Acetylcytidine,1TMS,isomer #3CC(=O)NC1=NC(=O)N([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O[Si](C)(C)C)C=C12698.5Semi standard non polar33892256
N4-Acetylcytidine,1TMS,isomer #4CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C=C1)[Si](C)(C)C2486.3Semi standard non polar33892256
N4-Acetylcytidine,2TMS,isomer #1CC(=O)NC1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O)C=C12665.7Semi standard non polar33892256
N4-Acetylcytidine,2TMS,isomer #2CC(=O)NC1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O)[C@H]2O[Si](C)(C)C)C=C12659.0Semi standard non polar33892256
N4-Acetylcytidine,2TMS,isomer #3CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O)[C@H]2O)C=C1)[Si](C)(C)C2462.4Semi standard non polar33892256
N4-Acetylcytidine,2TMS,isomer #4CC(=O)NC1=NC(=O)N([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C=C12652.2Semi standard non polar33892256
N4-Acetylcytidine,2TMS,isomer #5CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C)[C@H]2O)C=C1)[Si](C)(C)C2464.4Semi standard non polar33892256
N4-Acetylcytidine,2TMS,isomer #6CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O[Si](C)(C)C)C=C1)[Si](C)(C)C2448.7Semi standard non polar33892256
N4-Acetylcytidine,3TMS,isomer #1CC(=O)NC1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C=C12616.3Semi standard non polar33892256
N4-Acetylcytidine,3TMS,isomer #2CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O)C=C1)[Si](C)(C)C2475.5Semi standard non polar33892256
N4-Acetylcytidine,3TMS,isomer #3CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O)[C@H]2O[Si](C)(C)C)C=C1)[Si](C)(C)C2476.3Semi standard non polar33892256
N4-Acetylcytidine,3TMS,isomer #4CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C=C1)[Si](C)(C)C2475.6Semi standard non polar33892256
N4-Acetylcytidine,4TMS,isomer #1CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C=C1)[Si](C)(C)C2507.9Semi standard non polar33892256
N4-Acetylcytidine,4TMS,isomer #1CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C=C1)[Si](C)(C)C2644.3Standard non polar33892256
N4-Acetylcytidine,4TMS,isomer #1CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C=C1)[Si](C)(C)C2953.8Standard polar33892256
N4-Acetylcytidine,1TBDMS,isomer #1CC(=O)NC1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]2O)C=C12969.4Semi standard non polar33892256
N4-Acetylcytidine,1TBDMS,isomer #2CC(=O)NC1=NC(=O)N([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C=C12968.4Semi standard non polar33892256
N4-Acetylcytidine,1TBDMS,isomer #3CC(=O)NC1=NC(=O)N([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C=C12952.3Semi standard non polar33892256
N4-Acetylcytidine,1TBDMS,isomer #4CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C=C1)[Si](C)(C)C(C)(C)C2725.1Semi standard non polar33892256
N4-Acetylcytidine,2TBDMS,isomer #1CC(=O)NC1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C=C13159.2Semi standard non polar33892256
N4-Acetylcytidine,2TBDMS,isomer #2CC(=O)NC1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C=C13158.4Semi standard non polar33892256
N4-Acetylcytidine,2TBDMS,isomer #3CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]2O)C=C1)[Si](C)(C)C(C)(C)C2911.2Semi standard non polar33892256
N4-Acetylcytidine,2TBDMS,isomer #4CC(=O)NC1=NC(=O)N([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C=C13138.5Semi standard non polar33892256
N4-Acetylcytidine,2TBDMS,isomer #5CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C=C1)[Si](C)(C)C(C)(C)C2927.0Semi standard non polar33892256
N4-Acetylcytidine,2TBDMS,isomer #6CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C=C1)[Si](C)(C)C(C)(C)C2912.8Semi standard non polar33892256
N4-Acetylcytidine,3TBDMS,isomer #1CC(=O)NC1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C=C13335.9Semi standard non polar33892256
N4-Acetylcytidine,3TBDMS,isomer #2CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C=C1)[Si](C)(C)C(C)(C)C3109.9Semi standard non polar33892256
N4-Acetylcytidine,3TBDMS,isomer #3CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C=C1)[Si](C)(C)C(C)(C)C3118.2Semi standard non polar33892256
N4-Acetylcytidine,3TBDMS,isomer #4CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C=C1)[Si](C)(C)C(C)(C)C3114.8Semi standard non polar33892256
N4-Acetylcytidine,4TBDMS,isomer #1CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C=C1)[Si](C)(C)C(C)(C)C3290.7Semi standard non polar33892256
N4-Acetylcytidine,4TBDMS,isomer #1CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C=C1)[Si](C)(C)C(C)(C)C3337.7Standard non polar33892256
N4-Acetylcytidine,4TBDMS,isomer #1CC(=O)N(C1=NC(=O)N([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C=C1)[Si](C)(C)C(C)(C)C3331.7Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - N4-Acetylcytidine GC-MS (Non-derivatized) - 70eV, Positivesplash10-0avi-9260000000-457a65448f2b7f997b8e2017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - N4-Acetylcytidine GC-MS (3 TMS) - 70eV, Positivesplash10-00n0-7733900000-21a157f49e2b5c590e792017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - N4-Acetylcytidine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental LC-MS/MSLC-MS/MS Spectrum - N4-Acetylcytidine 35V, Negative-QTOFsplash10-0a4i-0910000000-c60f41d3d945b79d13eb2021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - N4-Acetylcytidine 35V, Positive-QTOFsplash10-03di-0900000000-d9bb0feb4836d04f80b92021-09-20HMDB team, MONAView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N4-Acetylcytidine 10V, Positive-QTOFsplash10-0udi-0950000000-d29714fc1fde544809252016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N4-Acetylcytidine 20V, Positive-QTOFsplash10-0udi-2930000000-6f0a2c07a23e5a0c4ed82016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N4-Acetylcytidine 40V, Positive-QTOFsplash10-0uds-3900000000-79b2c1a24f98018ce91a2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N4-Acetylcytidine 10V, Negative-QTOFsplash10-0uec-0890000000-ae426cb4fd63f76b745c2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N4-Acetylcytidine 20V, Negative-QTOFsplash10-0udi-1940000000-b5dd7d54b875099f3c732016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N4-Acetylcytidine 40V, Negative-QTOFsplash10-0006-9400000000-b6b80dc5931b68b998262016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N4-Acetylcytidine 10V, Negative-QTOFsplash10-0gx3-0960000000-77953fd09d47227f609c2021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N4-Acetylcytidine 20V, Negative-QTOFsplash10-03k9-0900000000-f79c56b7470dab72e2e02021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N4-Acetylcytidine 40V, Negative-QTOFsplash10-006x-9700000000-2d2354944eb07a47ad152021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N4-Acetylcytidine 10V, Positive-QTOFsplash10-0udi-0900000000-1a973cafe87881a4871b2021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N4-Acetylcytidine 20V, Positive-QTOFsplash10-03di-0900000000-540faca94381a30183232021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N4-Acetylcytidine 40V, Positive-QTOFsplash10-03di-4900000000-56cd92e7d1e1be7080cd2021-09-24Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
  • Urine
Tissue Locations
  • Placenta
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected and Quantified0.200 +/- 0.0600 uMAdult (>18 years old)Both
Normal
details
Abnormal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected and Quantified0.560 +/- 0.108 uMAdult (>18 years old)Both
Uremia
details
UrineDetected but not QuantifiedNot QuantifiedAdult (>18 years old)FemaleEpithelial ovarian cancer details
Associated Disorders and Diseases
Disease References
Uremia
  1. Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W: Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003 May;63(5):1934-43. doi: 10.1046/j.1523-1755.2003.00924.x. [PubMed:12675874 ]
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDFDB023789
KNApSAcK IDNot Available
Chemspider ID96702
KEGG Compound IDNot Available
BioCyc IDCPD-11648
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound107461
PDB IDNot Available
ChEBI ID70989
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDMDB00029896
Good Scents IDrw1268071
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Download (PDF)
General References
  1. Morris GS, Simmonds HA, Davies PM: Use of biological fluids for the rapid diagnosis of potentially lethal inherited disorders of human purine and pyrimidine metabolism. Biomed Chromatogr. 1986 Jun;1(3):109-18. [PubMed:3506820 ]
  2. Zheng YF, Yang J, Zhao XJ, Feng B, Kong HW, Chen YJ, Lv S, Zheng MH, Xu GW: Urinary nucleosides as biological markers for patients with colorectal cancer. World J Gastroenterol. 2005 Jul 7;11(25):3871-6. [PubMed:15991285 ]
  3. Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]